Use of Somarajyadi lepa and its ointment in psoriasis

Randomized controlled clinical trials to evaluate the efficacy of Somarajyadi lepa and its ointment in case of Dushivishjanya Ekakustha w.s.r to Psoriasis.. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085437

Enrollment

Registered

2025-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients diagnosed with Dushivishjanya Ekakushta. 2.Age Group above 5 years. 3.Patient of either sex.

Exclusion criteria

Exclusion criteria: 1.Patients of osteoarthritis, Rheumatoid arthritis,SLE,psoratic arthritis,postular valgarius. 2.Psoriasis vulgarius associated with other complicate disease. 3.Patients having Diabetes mellitus,koche. 4.Patients with HIV,VDRL,HBsAg positive. 5. Non willing patients.

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Somarajyadi lepa in its onintment in EkakushtaTimepoint: On 7th,14th,21st,28th day of trial.	—

Secondary

Measure	Time frame
1.To study the Somarajyadi lepa in detail. 2.To study Ekakushta in detail as per ayurveda and modern text. 3.Authentification and standardization of raw ingredients of Somarajyadi lepa. 4.Pharmacetical and analytical study of Somarajyadi ointment. 5.Safty study in vivo authorised animals testing labTimepoint: On 7th,14th,21th,28th day of trial.	—

Countries

India

Contacts

Public ContactDr S P Mirajkar Koparde

GAC Dharashiv

drkopardesheetal@gmail.com9326141020

Outcome results